O.C.G.A.

O.C.G.A. § 16-13-4 (2019)

Approval by Food and Drug Administration as prerequisite to sale of controlled substances and dangerous drugs

✓ O.C.G.A. — 2019 edition (Public.Resource.Org Release 73)
Code text and O.C.G.A. statutory annotations on this page reflect the 2019 Official Code of Georgia Annotated (Public.Resource.Org Release 73, 2019-08-21; public domain per Georgia v. Public.Resource.Org, 2020). The Syfert case-law annotations in Notes of Decisions, below, are current.
Find cases: SyfertCases citing this section GA-LEGlegis.ga.gov (official) JustiaJustia CornellLII Search CasesGoogle Scholar

(a) No controlled substance or dangerous drug shall be sold for dispensing unless the controlled substance, as defined in Code Section 16-13-21, or the dangerous drug, as defined in Code Section 16-13-71:

(1) Is approved by the Food and Drug Administration for resale;

(2) Has a new approved drug application number (known as an NDA number) unless excepted by the Food and Drug Administration; or

(3) Has an approved abbreviated new drug application number (known as an ANDA number) unless excepted by the Food and Drug Administration.

(b) Any person who violates subsection (a) of this Code section shall be guilty of a felony and, upon conviction thereof, shall be punished by imprisonment of not less than one year nor more than five years.

History

Ga. L. 1981, p. 557, § 6; Ga. L. 1985, p. 1219, § 1; Ga. L. 1989, p. 14, § 16.

Notes of Decisions
Cited in 1 case, 2005–2005 · leading case: Garibay v. State, 620 S.E.2d 424 (Ga. Ct. App. 2005).
Garibay v. State, 620 S.E.2d 424 (Ga. Ct. App. 2005). · cites it 2× “3 Presumably Garibay meant OCGA § 16-15-4, though his brief cites OCGA § 16-13-4 (“Approval by Food and Drug Administration as prerequisite to sale of controlled substances and dangerous drugs”).”
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.